Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Allergies
Research from N. Schmitz and co-authors provides new data about allergies
November 4th, 2009
According to a study from Schlieren, Switzerland, "Allergen-specific desensitization is the only disease-modifying therapy currently available for the treatment of allergies. These therapies require application of allergen over several years and some may induce life-threatening anaphylactic reactions." "An ideal vaccine for desensitization should be highly immunogenic and should alleviate allergic symptoms upon few injections while being nonreactogenic. We describe such a vaccine for the treatment of cat allergy, consisting of the major cat allergen Fel d1 coupled to bacteriophage Q beta-derived virus-like particles (Q beta-Fel d1). Q beta-Fel d1 was highly immunogenic,...
Source: Vaccine Weekly (2009-11-04)
|
